RUNX1 and cancer: To specifically study the consequence of C-terminal RUNX1 deletions in cancers, Satoh et al. expressed a deletion mutant lacking 225 amino acids (RUNX1dc) from the C-terminus of RUNX1 in murine hematopoietic stem and progenitor cells (HSPCs) [45] (Figure 2).